Skip to content
10-Q

Quarterly Report

SIGNPATH PHARMA, INC.

0001096906-15-000581

← back to feed
Filed
May 20, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · May 14, 2015 14.16M sh
Stockholders Equity Q1 2015 · Mar 31, 2015 $726.09K
Stockholders Equity Q1 2015 · Dec 31, 2014 $268.19K
Current Liabilities Q1 2015 · Mar 31, 2015 $317.07K
Current Liabilities Q1 2015 · Dec 31, 2014 $448K
Current Assets Q1 2015 · Mar 31, 2015 $1.04M
Current Assets Q1 2015 · Dec 31, 2014 $716.19K
Total Assets Q1 2015 · Mar 31, 2015 $1.04M
Total Assets Q1 2015 · Dec 31, 2014 $716.19K
Operating Cash Flow Q1 2015 · Mar 31, 2014 −$334.1K
Sga Expense Q1 2015 · Mar 31, 2014 $7.76K
Rd Expense Q1 2015 · Mar 31, 2014 $129.79K
Net Income Q1 2015 · Mar 31, 2014 −$198.17K
Operating Income restated Q1 2015 · Mar 31, 2014 $198.37K